487 related articles for article (PubMed ID: 18505952)
1. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.
Dong LM; Potter JD; White E; Ulrich CM; Cardon LR; Peters U
JAMA; 2008 May; 299(20):2423-36. PubMed ID: 18505952
[TBL] [Abstract][Full Text] [Related]
2. Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses.
Liao G; Wang Y; Zhou YQ; Li TW; Zeng DQ; Zeng X; Li J; Dan HX; Chen QM
Oral Dis; 2014 Oct; 20(7):644-9. PubMed ID: 24102947
[TBL] [Abstract][Full Text] [Related]
3. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
4. Bayesian statistical methods in genetic association studies: Empirical examination of statistically non-significant Genome Wide Association Study (GWAS) meta-analyses in cancers: A systematic review.
Park JH; Geum DI; Eisenhut M; van der Vliet HJ; Shin JI
Gene; 2019 Feb; 685():170-178. PubMed ID: 30416053
[TBL] [Abstract][Full Text] [Related]
5. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.
Vijayakrishnan J; Houlston RS
Haematologica; 2010 Aug; 95(8):1405-14. PubMed ID: 20511665
[TBL] [Abstract][Full Text] [Related]
6. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
Miao LF; Ye XH; He XF
PLoS One; 2020; 15(3):e0216147. PubMed ID: 32155154
[TBL] [Abstract][Full Text] [Related]
7. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta-analysis.
Park JH; Jeong GH; Lee KS; Lee KH; Suh JS; Eisenhut M; van der Vliet HJ; Kronbichler A; Stubbs B; Solmi M; Dragioti E; Koyanagi A; Shin JI; Gamerith G
Eur J Clin Invest; 2020 Apr; 50(4):e13203. PubMed ID: 31984489
[TBL] [Abstract][Full Text] [Related]
10. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
Liu C; Cui H; Gu D; Zhang M; Fang Y; Chen S; Tang M; Zhang B; Chen H
Lung Cancer; 2017 Nov; 113():18-29. PubMed ID: 29110844
[TBL] [Abstract][Full Text] [Related]
13. Field Synopsis and Re-analysis of Systematic Meta-analyses of Genetic Association Studies in Multiple Sclerosis: a Bayesian Approach.
Park JH; Kim JH; Jo KE; Na SW; Eisenhut M; Kronbichler A; Lee KH; Shin JI
Mol Neurobiol; 2018 Jul; 55(7):5672-5688. PubMed ID: 29027112
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
McGrath M; Michaud D; De Vivo I
BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
[TBL] [Abstract][Full Text] [Related]
15. The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants.
Tong X; Ma Y; Niu X; Yan Z; Liu S; Peng B; Peng S; Fan H
Medicine (Baltimore); 2016 Jul; 95(30):e4325. PubMed ID: 27472712
[TBL] [Abstract][Full Text] [Related]
16. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
[TBL] [Abstract][Full Text] [Related]
17. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.
Montazeri Z; Theodoratou E; Nyiraneza C; Timofeeva M; Chen W; Svinti V; Sivakumaran S; Gresham G; Cubitt L; Carvajal-Carmona L; Bertagnolli MM; Zauber AG; Tomlinson I; Farrington SM; Dunlop MG; Campbell H; Little J
Int J Epidemiol; 2016 Feb; 45(1):186-205. PubMed ID: 26451011
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
19. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
20. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer.
Hashibe M; Brennan P; Strange RC; Bhisey R; Cascorbi I; Lazarus P; Oude Ophuis MB; Benhamou S; Foulkes WD; Katoh T; Coutelle C; Romkes M; Gaspari L; Taioli E; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1509-17. PubMed ID: 14693745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
